Asthma in elderly and coronavirus disease 2019
Once the first wave of severe acute respiratory syndrome coronavirus 2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy.1 Symptoms persisting 3 to 6 months after acute coronavirus disease 2019 (COVID-19) (post –COVID-19 syndrome) have been described.2-5 Currently, there is a lack of information on post–COVID-19 consequences in elderly patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Coronavirus | COVID-19 | Respiratory Medicine | SARS